Prognostic Factors in Central Neurocytomas
Authors:
- Alexandre VasiljevicAVAlexandre Vasiljevic
- Patrick FrançoisPFPatrick François
- Anderson LoundouALAnderson Loundou
- Michelle Fèvre-MontangeMFMichelle Fèvre-Montange
- Anne JouvetAJAnne Jouvet
- Pierre-Hugues RochePRPierre-Hugues Roche
- Dominique Figarella-BrangerDFDominique Figarella-Branger
- 1 February 2012
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 36 (2) , 220-227
Abstract
Central neurocytoma (CN) is a rare intraventricular tumor presenting a benign histologic appearance and favorable prognosis after surgery. In contrast, "atypical" CN is defined by a high MIB1 proliferation index and/or histologic features of malignancy, which are associated with a poorer outcome. This variant of CN remains somewhat controversial. To better characterize CN and its "atypical" variant, a retrospective multicenter study was conducted on 71 patients presenting with CN. A statistical analysis of clinical, radiologic, and histologic data was conducted to validate prognostic factors. The immunohistochemical phenotype of CNs, analyzed by tissue microarrays, and the MIB1 index were evaluated for 45 cases. Tissue microarrays validated the expression of neuronal markers synaptophysin and NeuN, but not that of glial markers glial fibrillary acidic protein and oligodendrocyte transcription factor 2. In the univariate analysis, a tumor volume ≥30 cm (P=0.025), incomplete surgery (P=0.033), and a mitotic count ≥3 per 10 high-power fields (P=0.009) were predictors of a higher risk of recurrence, unlike the other usual histologic features of malignancy and the high MIB1 index. Partial surgery was the only criterion associated with a poorer outcome in the multivariate model. Our results, based on a large multicenter series, show the striking homogeneity of CNs and do not support the use of histologic criteria as reliable markers to define an "atypical" group of CNs. Our study suggests that the extent of surgery is the main factor to be considered in the prognostic assessment of patients with CN.Keywords
This publication has 39 references indexed in Scilit:
- Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphologyActa Neuropathologica, 2010
- Treatment of atypical central neurocytoma in a child with high dose chemotherapy and autologous stem cell rescueJournal of Neuro-Oncology, 2009
- Recurrent central neurocytomasCancer, 2005
- NeuN expression correlates with reduced mitotic index of neoplastic cells in central neurocytomasNeuropathology and Applied Neurobiology, 2005
- Central Neurocytoma with Craniospinal DisseminationMagnetic Resonance in Medical Sciences, 2002
- Benign central neurocytomaCancer, 2000
- Central neurocytoma with malignant coursePathology and Oncology Research, 1999
- Craniospinal dissemination of central neurocytomaJournal of Neurosurgery, 1997
- Central NeurocytomasAmerican Journal of Surgical Pathology, 1992
- Central neurocytomaActa Neuropathologica, 1982